Literature DB >> 15375742

Antibiotic use in Germany and European comparison.

K De With1, H Schröder, E Meyer, K Nink, S Hoffmann, M Steib-Bauert, R Kämmerer, S Ruess, F D Daschner, W V Kern.   

Abstract

In view of increasing rates of antibiotic resistance worldwide and decreased research and development of new antibacterial compounds, programmes helping to better understand the complex relationship between antibiotic consumption and emergence of resistance have gained importance. Consequently, in addition to increased support for research projects that establish prospective surveillance and evaluation of antibiotic resistance and antimicrobial drug use, the EU has passed directives addressing political leadership in this respect. Information on antibiotic use in Germany is now available from databases independent from cost-oriented market research studies. This information allows estimation of antibiotic use in ambulatory and hospital care as compared with to other EU countries. According to results of current projects, the frequency of national antibiotic use in ambulatory care in Germany (4948 defined daily doses per 1000 population per year) falls within the lower third of EU countries. Upper boundaries in regional variation in antibiotic use are still much lower than values for high-use countries like France, Spain and Portugal. Hospital antibiotic use, in contrast, appears to be in the range of that reported for other countries. However, only rough estimates of hospital antibiotic use are available for Germany as well as most other EU countries due to data usually derived from non-representative hospital sampling.

Mesh:

Substances:

Year:  2004        PMID: 15375742     DOI: 10.1055/s-2004-831838

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  8 in total

1.  Regional variations in community consumption of antibiotics in Hungary, 1996-2003.

Authors:  Maria Matuz; Ria Benko; Peter Doro; Edit Hajdu; Gabor Nagy; Erzsebet Nagy; Dominique L Monnet; Gyongyver Soos
Journal:  Br J Clin Pharmacol       Date:  2006-01       Impact factor: 4.335

2.  A national cross-sectional study on socio-behavioural factors that influence physicians' decisions to begin antimicrobial therapy.

Authors:  E Velasco; W Espelage; M Faber; I Noll; A Ziegelmann; G Krause; T Eckmanns
Journal:  Infection       Date:  2011-06-30       Impact factor: 3.553

3.  [Between promise and threat : antibiotics in foods in west Germany 1950-1980].

Authors:  Ulrike Thoms
Journal:  NTM       Date:  2012

4.  Outpatient Antibiotic Prescription.

Authors:  Jörg Bätzing-Feigenbaum; Maike Schulz; Mandy Schulz; Ramona Hering; Winfried V Kern
Journal:  Dtsch Arztebl Int       Date:  2016-07-01       Impact factor: 5.594

Review 5.  [Procalcitonin-based algorithm. Management of antibiotic therapy in critically ill patients].

Authors:  M Hochreiter; S Schroeder
Journal:  Anaesthesist       Date:  2011-07       Impact factor: 1.041

6.  A survey of outpatient antibiotic prescribing for cystitis.

Authors:  Edward Velasco; Ines Noll; Werner Espelage; Antina Ziegelmann; Gérard Krause; Tim Eckmanns
Journal:  Dtsch Arztebl Int       Date:  2012-12-14       Impact factor: 5.594

Review 7.  [Diagnostic markers and assessment of efficacy of antibacterial therapy].

Authors:  K-F Bodmann
Journal:  Med Klin Intensivmed Notfmed       Date:  2014-04-05       Impact factor: 0.840

8.  Converting habits of antibiotic prescribing for respiratory tract infections in German primary care--the cluster-randomized controlled CHANGE-2 trial.

Authors:  Attila Altiner; Reinhard Berner; Annette Diener; Gregor Feldmeier; Anna Köchling; Christin Löffler; Helmut Schröder; Achim Siegel; Anja Wollny; Winfried V Kern
Journal:  BMC Fam Pract       Date:  2012-12-20       Impact factor: 2.497

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.